Showing 1 - 10 of 98
company:(1) has a patent needed to use a standard, (2) promises to license the patent on reasonable terms, and then (3) says … “patent holdup.”The concerns threatened by patent holdup have consistently been acknowledged by officials in Republican and … Antitrust in Preventing Patent Holdup. In contrast, they are neglected by the current Assistant Attorney General of the …
Persistent link: https://www.econbiz.de/10012831378
. Standard-essential patents, the smartphone patent wars, and patent trolls thrust themselves onto the IP/antitrust scene. But … perhaps the most significant change is the complete reversal of fortune undergone by drug patent settlements.Settlements by … finishing touches on their framework of near-complete deference to the settlements based on a "scope of the patent" test.But by …
Persistent link: https://www.econbiz.de/10013010245
.S. Patent and Trademark Office (“PTO”). Third, we apply the Supreme Court's four-factor eBay test to conclude that courts should …
Persistent link: https://www.econbiz.de/10012953068
of agreements by which brand-name drug companies pay generics to settle patent litigation and delay entering the market … of the patent" test applied by the dissent and several appellate courts — would have meant "game over" for challenges to …
Persistent link: https://www.econbiz.de/10014155650
Motorola and Samsung, and the Department of Justice’s approval of the patent portfolio acquisitions of Novell, Nortel, and …
Persistent link: https://www.econbiz.de/10014040898
Whether behavior relating to a patent thicket presents an antitrust issue is a nuanced question. But a recent ruling … highlights its errors analyzing sham behavior, patent settlements, and antitrust injury …
Persistent link: https://www.econbiz.de/10014094366
to delay entering the market. Such conduct requires courts to consider not only patent and antitrust law, but also the … by relying on a test that asks if the settlement falls within the “scope of the patent.” They have found, in nearly all ….This 8-page article shows why the scope test is not appropriate in determining the antitrust treatment of drug patent …
Persistent link: https://www.econbiz.de/10013100789
In GSK v. Teva, the Federal Circuit (in a 2-1 ruling) found that Teva induced infringement of GSK's patent. While much … uses not covered by the patent. The Federal Circuit found that this long-recognized practice of skinny labeling could form …
Persistent link: https://www.econbiz.de/10013244138
This comment supports the draft policy statement, explaining how it presents a welcome return to the bipartisan balanced treatment of standard essential patents that—with the exception of the period from 2017 to 2020—has applied for the past two decades. The comment discusses the statement's...
Persistent link: https://www.econbiz.de/10013300232
settlements must assume that the patent at issue is invalid or not infringed, since this is a problem of patent, not antitrust …, law. This symposium essay critiques Roberts' position. It explains that this position (1) shortchanges patent law, which …
Persistent link: https://www.econbiz.de/10013062809